Model self-assembling arginine-based tripeptides show selective activity against Pseudomonas bacteria.

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Pseudomonas aeruginosa is an opportunistic pathogen known for its resistance to antibiotics.
• Antimicrobial peptides are a promising class of therapeutic agents.
• Disrupting bacterial membranes and interfering with signaling pathways are key strategies for combating infections.

Purpose of the Study:

• To investigate the potential of three arginine-rich tripeptides (RXR) as antimicrobial agents.
• To evaluate their efficacy against Pseudomonas aeruginosa, focusing on membrane lysis.
• To explore the relationship between tripeptide activity and the second messenger cyclic di-GMP in biofilms.

Main Methods:

• Synthesis and characterization of three model arginine-rich tripeptides: RXR, where X was Tryptophan (RWR), Phenylalanine (RFR), or 2-naphthylalanine.
• Assessment of antimicrobial activity against planktonic Pseudomonas aeruginosa.
• Evaluation of activity against Pseudomonas aeruginosa biofilms.
• Investigation of the binding interaction with cyclic di-GMP.

Main Results:

• RFR and RWR tripeptides demonstrated strong selective antimicrobial activity against planktonic Pseudomonas aeruginosa.
• The antimicrobial activity against biofilms was correlated with the tripeptides' ability to bind to cyclic di-GMP.
• The non-natural residue 2-naphthylalanine variant showed specific activity profiles.

Conclusions:

• Arginine-rich tripeptides, particularly RFR and RWR, are effective agents against planktonic Pseudomonas aeruginosa.
• Targeting cyclic di-GMP binding is a viable strategy for developing anti-biofilm agents.
• These tripeptides represent potential leads for novel antimicrobial therapies against P. aeruginosa infections.